Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy

by Peng-Chan Lin, Yu-Min Yeh, Ren-Hao Chan, Bo-Wen Lin, Po-Chuan Chen, Chien-Chang Pan, Meng-Ru Shen
Published 2021-03-01

Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer

by Ren-Hao Chan, Peng-Chan Lin, Shang-Hung Chen, Shao-Chieh Lin, Po-Chuan Chen, Bo-Wen Lin, Meng-Ru Shen, Yu-Min Yeh
Published 2021-03-01

Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA

by Yu-Min Yeh, Peng-Chan Lin, Chung-Ta Lee, Shang-Hung Chen, Bo-Wen Lin, Shao-Chieh Lin, Po-Chuan Chen, Ren-Hao Chan, Meng-Ru Shen
Published 2020-10-01

Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers

by Peng-Chan Lin, Yu-Min Yeh, Hui-Ping Hsu, Ren-Hao Chan, Bo-Wen Lin, Po-Chuan Chen, Chien-Chang Pan, Keng-Fu Hsu, Jenn-Ren Hsiao, Yan-Shen Shan, Meng-Ru Shen
Published 2021-08-01

Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer

by Peng-Chan Lin, Peng-Chan Lin, Peng-Chan Lin, Yu-Min Yeh, Yu-Min Yeh, Bo-Wen Lin, Shao-Chieh Lin, Ren-Hao Chan, Po-Chuan Chen, Meng-Ru Shen, Meng-Ru Shen, Meng-Ru Shen
Published 2020-10-01